In Alzheimer’s disease, routine clinical use of PET is limited by cost & accessibility.

But can one predict PET composite values from more accessible data?

A nice study elucidating promising & limiting aspects of using ML to predict tau-PET from plasma biomarkers & MRI.

#dementia #alzsky
Reposted from
🚨New paper published in @alzdemjournals! doi.org/10.1002/alz.14600

PhD student Linda Karlsson et al. use machine learning (ML) to predict tau-PET composites from accessible and inexpensive modalities: plasma biomarkers, structural MRI and clinical variables. Details 👇

Comments